Nosopharm welcomes Jacques Biton and Frédéric Hammel to its supervisory board
Alaxia joins EU consortium to combat drug-resistant lung infections
Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia
Minoryx Therapeutics completes enrollment in FRAMES phase 2 trial with leriglitazone in Friedreich’s Ataxia
Domain Therapeutics reaches two milestones in multi-target research collaboration with Boehringer Ingelheim
Yposkesi to host roundtable on challenges in gene therapy manufacturing at the Cell and Gene Meeting on the Mesa, October 2-4
Imcyse to present first-in-human phase 1b study results in type 1 diabetes at EASD 2019
Imcyse to present positive results in EAE model of multiple sclerosis at ECTRIMS 2019